<DOC>
	<DOCNO>NCT00834223</DOCNO>
	<brief_summary>A prospective , multicenter , open-label , safety preliminary efficacy study surgical implantation OPKO 's glaucoma drainage device ( AquashuntTM ) patient refractory chronic form open angle glaucoma ( OAG ) . The primary objective study evaluate surgical implantation , safety preliminary efficacy AquashuntTM implantation patient refractory chronic form OAG</brief_summary>
	<brief_title>A Prospective , Multicenter , Open-label , Safety Preliminary Efficacy Study Surgical Implantation OPKO 's Glaucoma Drainage Device ( AquashuntTM ) Patients With Refractory Chronic Forms Open Angle Glaucoma ( OAG )</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<criteria>Patients either sex eligible study follow criterion meet : 1 . Patients must age 18 year . 2 . Patients must diagnosis chronic form open angle glaucoma study eye , uncontrolled maximum tolerate medical treatment ocular hypotensive medication fail glaucoma surgery consider reasonable candidate traditional surgery . 3 . The patient 's documented IOP must consider treat physician high glaucoma status . 4 . Patients must BCVA 20/400 Light Perception , light perception pain , study eye . 5 . Patients must BCVA fellow eye , good study eye . 6 . Patients must mentally competent willing provide inform consent . 7 . Patients must willing return study visit assessment least 3 year surgery . Exclusion Criteria Patients eligible study follow criterion present : 1 . Patients diagnosis glaucoma open angle glaucoma include active uveitic , active neovascular recent traumatic glaucoma . 2 . Patients clinically significant corneal disease include corneal dystrophy . 3 . Patients iridocorneal endothelial syndrome . 4 . Any previous ocular surgery trabeculectomy , trabeculoplasty cataract surgery surgery ( include laser ) within previous 3 month . 5 . Patients Anterior Chamber configuration put patient high risk development angle closure glaucoma . 6 . Patients recent ( within previous 30 day ) , current , ocular/periocular inflammation infection . 7 . Patients history extensive keloid formation . 8 . Patients need ancillary procedure study eye time implantation initial one year study period . 9 . Patients know intolerance hypersensitivity topical anesthetic , mydriatic component device . 10 . Patients unable interrupt anticoagulant , antiplatelet NSAID ( include aspirin ) therapy least 3 week prior surgery . 11 . Patients within previous 3 month , currently , intend participate study investigational agent ( drug device ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>refractory chronic form open angle glaucoma ( OAG )</keyword>
	<keyword>OAG</keyword>
	<keyword>glaucoma</keyword>
</DOC>